Back
Catalyst Pharmaceuticals Vs. Lyell Immunopharma Industry Stock Comparison
Sell
45
CPRX
Catalyst Pharmaceuticals
Last Price:
14.75
Seasonality Move:
2.11%
Sell
50
LYEL
Lyell Immunopharma
Last Price:
2.45
Seasonality Move:
16.81%
Sell
45
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $15.11. The Score for CPRX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Lyell Immunopharma (LYEL)
is a Sell
Is Lyell Immunopharma a Buy, Sell or Hold?
- The current Lyell Immunopharma [LYEL] share price is $2.41. The Score for LYEL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- LYEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $15.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight selling pressure.
LYEL Stock Price Chart
What is Lyell Immunopharma's stock price today?
-
The Lyell Immunopharma share price today is $2.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing buying pressure, which is a positive indicator for future bullish movement.
CPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 44.35 | Sell |
Chaikin Money Flow: | -112021 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.25 - 16.19) | Sell |
Bollinger Bands (100): | (14.01 - 16.19) | Buy |
LYEL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 52.75 | Buy |
Chaikin Money Flow: | 715406 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.98 - 2.48) | Buy |
Bollinger Bands (100): | (1.84 - 2.42) | Buy |
CPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.44 | Sell |
20-day SMA: | 15.57 | Sell |
50-day SMA: | 15.39 | Sell |
200-day SMA: | 14.16 | Buy |
8-day EMA: | 15.39 | Sell |
20-day EMA: | 15.54 | Sell |
50-day EMA: | 15.41 | Sell |
200-day EMA: | 14.57 | Buy |
LYEL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.48 | Sell |
20-day SMA: | 2.28 | Buy |
50-day SMA: | 2.29 | Buy |
200-day SMA: | 2.11 | Buy |
8-day EMA: | 2.39 | Buy |
20-day EMA: | 2.34 | Buy |
50-day EMA: | 2.26 | Buy |
200-day EMA: | 2.34 | Buy |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.
Lyell Immunopharma Earnings Growth & LYEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.04 per share.
Catalyst Pharmaceuticals Technical Analysis
Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lyell Immunopharma Technical Analysis
Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |